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the training programme reﬂected in infection rates amongst HCW
falling from February onwards.
Conclusion: An increase in IC supplies and a robust, evidence
based training programme clariﬁed safe IC practices and increased
conﬁdence in the workplace. Education was a major contributor to
containing HCW EVD spread.
http://dx.doi.org/10.1016/j.ijid.2016.02.193
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Protecting the health care worker during
outbreaks – The case of viral hemorrhagic fever
outbreaks
H. De Clerck
Médecins Sans Frontières (MSF), Antwerp, Belgium
Abstract:MédecinsSansFrontières (MSF)/DoctorsWithoutBor-
ders, an International Medical Humanitarian Non Governmental
Organization, has an experience of 20 years in intervening in
Viral Hemorrhagic Fever (VHF)Outbreaks (Marburg-, Ebola-, Lassa-
fever-outbreaks).Healthcareproviders caring forEbola-,Marburg-,
and, in a lesser extend, Lassa-patients, are, next to family and
friends of patients, at highest risk of getting infected by those dis-
eases, as they are most likely to come in contact with infectious
blood and/or body ﬂuids of VHF patients. This was sadly pointed
out by the more than 880 Health Care Workers that got infected
with Ebola-virus in the recent 2013-2015 Ebola-outbreak in West-
Africa. More than 500 of them died. The protection of Health Care
Staff is, considering all this, not surprisingly, amain concern during
VHF outbreak interventions. In this talk MSF shares its experience
in how to do so: from Personal Protection Equipment, over HR
management and training and staff health policies to general inter-
vention strategies. We’ll try to give an overview of all activities
needed in order to guarantee, asmuch as possible, staff safety.We’ll
as well discuss challenges, recent developments and future needs
in the domain of Bio-safety and staff safety.
http://dx.doi.org/10.1016/j.ijid.2016.02.194
Type: Invited Presentation
Final Abstract Number: 40.001
Session: Sexually Transmitted Infections: Global Challenges
Date: Saturday, March 5, 2016
Time: 15:45-17:45
Room: G.01-03
HIV and syphilis
K. Mayer
The Fenway Institute, Boston, MA, USA
Abstract: HIV-infected people are at increased risk for syphilis,
partially because of their immunodeﬁciency, but particularly
because of ease of transmission of syphilis in sexually active people.
Unlike HIV, syphilis can readily be transmitted through insertive
or receptive oral sex. HIV-infected individuals, particularly men
who have sex with men with multiple partners and male or
female sex workers tend to have higher rates of HIV, syphilis and
co-infection than the general population in their respective com-
munities worldwide. The presentation of syphilis may be highly
diverse in HIV-infected patients, ranging from asymptomatic gum-
mas,whichmaybeobscuredby their location (e.g. inside the vagina
or rectum) to a wide array of maculopapular eruptions. Untreated
syphilis canbeparticularly virulent inHIV-infectedpatients, result-
ing in neurosyphilis, which can result in sensory, cognitive, and/or
ocular impairment, if left untreated in HIV-immunocompromised
patients. Conventional diagnostic assays for syphilis based on anti-
bodies to treponeme and non-treponeme antigens can be more
difﬁcult to interpret in HIV-infected, compared to uninfected,
patients, remaining reactive (“serofast”) long after successful treat-
ment has been completed. This poses a challenge to the clinician,
since inadequately treated syphilis can result in neurosyphilis. The
organism remains susceptible to penicillin in most cases, and in
all settings except for acute primary infection, treatment with 2
successive weekly courses of intramuscular benzathine penicillin
is indicated. Lumbar puncture should be done if neurosyphilis is
suspected, since the treatmentwould require higher doses of intra-
venous penicillin, if diagnosed. Rare cases of macrolide-resistant
syphilis have been reported, so second line treatment in penicillin
allergicpatients canconsist ofdailydoxycycline for3weeks, if peni-
cillin desensitization is not feasible. When HIV-infected patients
are severely immunocompromised, the initiation of antiretrovi-
ral therapy can result in an immune reconstitution inﬂammatory
syndrome if they have undiagnosed syphilis. Because of its high
prevalence in HIV-infected patients, syphilis screening should be
conducted quarterly in non-monogamous, sexually active HIV-
infected patients.
http://dx.doi.org/10.1016/j.ijid.2016.02.195
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Abstract: Acute prostatitis is usually a bacterial infection caused
by uropathogens and should be treated initially by broadspectrum
antimicrobials until the results from urine culture are available for
a more tailored antibiotic therapy. Only about 10% will become a
chronic prostatitis.
Chronic prostatitis-like symptoms in men may have multi-
factorial causes. Therefore, these patients should be investigated
thoroughly for various possible pathologies. A chronic infection of
the prostate may either be the cause or the consequence of such a
disease and
should be diagnosed properly or excluded. Uncritical use of
antimicrobials is by no means justiﬁed, because antibiotic therapy
may have adverse effects for the patient and/or collateral damage
for the environment.
Besides detailed history and clinical evaluation, the investiga-
tion for a chronic infectionof theprostate should only beperformed
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after the patient has stopped any antibiotic therapy for at least 4
weeks. If the midstream urine of the patient does not indicate any
urinary tract infection, a localization study should be performed.
Pathogens usually recognized as causing a chronic prostate
infection are the same as the traditional uropathogens (TP),
mainly E. coli, other Enterobacteriaceae, Pseudomonas aeruginosa,
and enterococci. But also non traditional pathogens (NTP) includ-
ing Gram-positive bacteria, such as staphylococci and streptococci,
and also ureaplasmas, mycoplasmas and especially Chlamydia tra-
chomatis (Skerk 2008). A gonococcal prostatitis may be fairly rare
and can be acute and chronic.
The ﬂuoroquinolones are recommended as drugs of choice in
chronic infection of the prostate, if the pathogens are susceptible,
because of their favourable prostate pharmacokinetics, which are
however different between the analogues. Clinical studieswith lev-
oﬂoxacin have shown, that our conventional dosage regimens may
have to be reconsidered in favour of higher dosages and probably
shorter treatment durations. In case of STI in addition macrolides
and tetracyclines may be included into the therapeutic armamen-
tarium.
In chronic pelvic pain syndrome (CPPS) where infection cannot
be found, phenotyping of the symptoms and a multimodal ther-
apy may be considered since such a complex syndrome may have
several underlying pathologies.
http://dx.doi.org/10.1016/j.ijid.2016.02.196
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Abstract: Every year cervical cancer affects around 528000
women and causes 266000 deaths worldwide with 80% of deaths
occurring in less developed countries with a concomitant 18-fold
difference in mortality occurring between developed and develop-
ing countries. Cervical cancers is caused by the Human Papilloma
Virus (HPV)with the oncogenic types 16 and 18 accounting for 70%
of invasive disease. Other cancers associated with HPV infection
include vaginal, vulvar, penile, oropharyngeal and anal cancers. In
addition, HPV types 6 and 11 cause anogenital warts and recurrent
respiratory papillomatosis. In 2009, the World Health Organisa-
tion issued the ﬁrst position paper on HPV vaccines, revised in
2014, in which it supported HPV vaccine introduction into national
immunization programmeswhere: ‘i) prevention of cervical cancer
and/or other HPV-related disease is a public health priority ii) the
introduction is programmatically feasible and economically sus-
tainable, and where iii) cost-effectiveness aspects have been duly
considered. They recommended that the primary target population
should be girls aged 9-13 years but that HPV vaccination ofmales is
not recommended as a priority, especially in resource-constrained
settings, as the available evidence indicates that the ﬁrst prior-
ity should be for cervical cancer reduction by timely vaccination
of young females and high coverage with each dose. In 2014 the
recommendations for HPV vaccine changed form a three dose to a
two-dose schedule.
In 2011 the Global Alliance on Vaccines and immunisation
(GAVI), tasked with supporting the introduction of new vac-
cines into the world’s poorest countries, approved support of HPV
vaccines introduction into GAVI eligible countries with the low
negotiated price of US$ 4.50 per dose compared to US$ 100 in high-
income countries. By 2015GAVI plans to support the immunisation
of approximately one million girls with HPV vaccines and by 2015
more than 30 million girls in less developed countries.
This presentationwill explore the reach, successes and epidemi-
ological impact of HPV vaccine introduction worldwide and will
consider some of the challenges such as the introduction of school
immunisationprogrammes, the immunisationof boys, and the con-
troversy around HPV vaccine introduction in India.
http://dx.doi.org/10.1016/j.ijid.2016.02.197
Type: Invited Presentation
Final Abstract Number: 40.004
Session: Sexually Transmitted Infections: Global Challenges
Date: Saturday, March 5, 2016
Time: 15:45-17:45
Room: G.01-03
Prospects of untreatable gonorrhea and ways
forward
T. Tbd
Abstract: (no abstract received from presenter)
http://dx.doi.org/10.1016/j.ijid.2016.02.198
Type: Poster Presentation
Final Abstract Number: 41.001
Session: Poster Session I
Date: Thursday, March 3, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Antimicrobial resistance, phylogenetic
distribution and molecular docking of integrons
in multidrug resistant diarrheagenic E.coli
isolates from children under ﬁve in Delhi, India.
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Background: Integrons are versatile gene acquisition systems
commonly found in bacterial genomes. They are ancient elements
that are a hot spot for genomic complexity, generating phenotypic
diversity and shaping adaptive responses. Mobile gene cassettes
captured within integron arrays encompass a vast and diverse
pool of genetic novelty. These elements are able to capture and
express gene cassettes encoding antibiotic resistance. The main
aim of this study was to investigate the distribution of integrons in
multidrug resistant diarrheagenic E.coli isolates, to analyze the pos-
sible relationship between the antimicrobial resistances proﬁles,
